Skip to main content
. 2016 May 27;36(2):641–650. doi: 10.3892/or.2016.4837

Figure 2.

Figure 2

Analysis of circulating Th17, Tc17 and γδT17 cells in patients with different tumor characteristics. The percentages of (A) Th17, (B) Tc17 and (C) γδT17 cells in patients with lung adenocarcinoma (LA) were compared according to tumor differentiation (good/moderate vs. poor), tumor invasion (T1+T2 vs. T3+T4), lymph node status (N0 vs. N1+N2+N3), metastasis (M0 vs. M1), and TNM stage (I+II and III+IV); The data shown represent the means ± SEM. *P<0.05, **P<0.01 were considered to represent significant differences.